The Efficacy of Transnasal Humidified Rapid-insufflation Ventilatory Exchange During Laryngeal Microsurgery
1 other identifier
interventional
126
1 country
1
Brief Summary
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) was revealed to prolong apneic time with a slow increase in carbon dioxide; thus, has been used for preoxygenation in patients with difficult airways or requiring rapid sequence induction in general anesthesia. However, in patients undergoing hypopharyngeal and laryngo-tracheal surgery, THRIVE during operation can be advantageous by allowing tubeless surgical field with sufficient oxygenation. Therefore, the investigators conducted this study to evaluate the efficacy of THRIVE on prolonged apneic time with enhanced surgical conditions in patients with laryngeal microsurgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2018
CompletedFirst Posted
Study publicly available on registry
August 14, 2018
CompletedStudy Start
First participant enrolled
August 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2020
CompletedNovember 20, 2020
September 1, 2018
1.5 years
August 9, 2018
November 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
lowest oxygen saturation
lowest oxygen saturation monitored by pulse oximetry during laryngeal microsurgery
from the time of starting laryngeal microsurgery till the end of the surgery
Secondary Outcomes (2)
lowest oxygen reserve index
from the time of starting laryngeal microsurgery till the end of the surgery
highest transcutaneous partial pressure of carbon dioxide
from the time of starting laryngeal microsurgery till the end of the surgery
Study Arms (2)
intubation group
EXPERIMENTALThe enrolled patients will be oxygenated by endotracheal tube during operation.
THRIVE group
EXPERIMENTALThe enrolled patients will be oxygenated by intubationless high flow nasal cannula during operation.
Interventions
After preoxygenation with FiO2 1.0 and flow rate of 8 L/min for 3 minutes, the enrolled patients will be intubated with endotracheal tube and maintained oxygenation during surgery.
After preoxygenation with 100% oxygen through high flow nasal cannula for 3 minutes, the enrolled patients will be maintained intubationless oxygenation with flow rate of 70 L/min during surgery.
Eligibility Criteria
You may qualify if:
- patients undergoing laryngeal microsurgery
- ASA class I-III
You may not qualify if:
- patients scheduled for laryngeal microsurgery using CO2 laser
- patients with increased intracranial pressure
- patients with skull base defect
- patients with chronic obstructive pulmonary disease
- patients with pulmonary hypertension
- patients requiring rapid sequence induction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 03080, South Korea
Related Publications (1)
Min SH, Yoon H, Huh G, Kwon SK, Seo JH, Cho YJ. Efficacy of high-flow nasal oxygenation compared with tracheal intubation for oxygenation during laryngeal microsurgery: a randomised non-inferiority study. Br J Anaesth. 2022 Jan;128(1):207-213. doi: 10.1016/j.bja.2021.09.016. Epub 2021 Oct 20.
PMID: 34688473DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Youn Joung Cho, MD
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical assistant professor
Study Record Dates
First Submitted
August 9, 2018
First Posted
August 14, 2018
Study Start
August 17, 2018
Primary Completion
February 24, 2020
Study Completion
February 24, 2020
Last Updated
November 20, 2020
Record last verified: 2018-09